Long-range and short-range tumor-stroma networks synergistically contribute to tumor-associated epilepsy
Epileptic seizures are frequently caused by brain tumors. Traditional anti-epileptic treatments do not acquire satisfactory responses. Preoperative and postoperative seizures seriously influence the quality of life of patients. Thus, tumor-associated epilepsy (TAE) is an important subject of the cur...
Saved in:
Published in | Oncotarget Vol. 7; no. 22; pp. 33451 - 33460 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Impact Journals LLC
31.05.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Epileptic seizures are frequently caused by brain tumors. Traditional anti-epileptic treatments do not acquire satisfactory responses. Preoperative and postoperative seizures seriously influence the quality of life of patients. Thus, tumor-associated epilepsy (TAE) is an important subject of the current research. The delineation of the etiology of epileptogenesis in patients with primary brain tumor may help to find the novel and effective drug targets for treating this disease. In this review, we describe the current status of treatment of TAE. More importantly, we focus on the factors that are involved in the functional connectivity between tumors and stromal cells. We propose that there exist two modes, namely, long-range and short-range modes, which likely trigger neuronal hyperexcitation and subsequent epileptic seizures. The long-range mode is referred to as factors released by tumors including glutamate and GABA, binding to the corresponding receptor on the cellular membrane and causing neuronal hyperactivity, while the short-range mode is considered to involve direct intracellular communication between tumor cells and stromas. Gap junctions and tunneling nanotube network are involved in cellular interconnections. Future investigations focused on those two modes may find a potential novel therapeutic target for treating TAE. |
---|---|
AbstractList | Epileptic seizures are frequently caused by brain tumors. Traditional anti-epileptic treatments do not acquire satisfactory responses. Preoperative and postoperative seizures seriously influence the quality of life of patients. Thus, tumor-associated epilepsy (TAE) is an important subject of the current research. The delineation of the etiology of epileptogenesis in patients with primary brain tumor may help to find the novel and effective drug targets for treating this disease. In this review, we describe the current status of treatment of TAE. More importantly, we focus on the factors that are involved in the functional connectivity between tumors and stromal cells. We propose that there exist two modes, namely, long-range and short-range modes, which likely trigger neuronal hyperexcitation and subsequent epileptic seizures. The long-range mode is referred to as factors released by tumors including glutamate and GABA, binding to the corresponding receptor on the cellular membrane and causing neuronal hyperactivity, while the short-range mode is considered to involve direct intracellular communication between tumor cells and stromas. Gap junctions and tunneling nanotube network are involved in cellular interconnections. Future investigations focused on those two modes may find a potential novel therapeutic target for treating TAE. Epileptic seizures are frequently caused by brain tumors. Traditional anti-epileptic treatments do not acquire satisfactory responses. Preoperative and postoperative seizures seriously influence the quality of life of patients. Thus, tumor-associated epilepsy (TAE) is an important subject of the current research. The delineation of the etiology of epileptogenesis in patients with primary brain tumor may help to find the novel and effective drug targets for treating this disease. In this review, we describe the current status of treatment of TAE. More importantly, we focus on the factors that are involved in the functional connectivity between tumors and stromal cells. We propose that there exist two modes, namely, long-range and short-range modes, which likely trigger neuronal hyperexcitation and subsequent epileptic seizures. The long-range mode is referred to as factors released by tumors including glutamate and GABA, binding to the corresponding receptor on the cellular membrane and causing neuronal hyperactivity, while the short-range mode is considered to involve direct intracellular communication between tumor cells and stromas. Gap junctions and tunneling nanotube network are involved in cellular interconnections. Future investigations focused on those two modes may find a potential novel therapeutic target for treating TAE.Epileptic seizures are frequently caused by brain tumors. Traditional anti-epileptic treatments do not acquire satisfactory responses. Preoperative and postoperative seizures seriously influence the quality of life of patients. Thus, tumor-associated epilepsy (TAE) is an important subject of the current research. The delineation of the etiology of epileptogenesis in patients with primary brain tumor may help to find the novel and effective drug targets for treating this disease. In this review, we describe the current status of treatment of TAE. More importantly, we focus on the factors that are involved in the functional connectivity between tumors and stromal cells. We propose that there exist two modes, namely, long-range and short-range modes, which likely trigger neuronal hyperexcitation and subsequent epileptic seizures. The long-range mode is referred to as factors released by tumors including glutamate and GABA, binding to the corresponding receptor on the cellular membrane and causing neuronal hyperactivity, while the short-range mode is considered to involve direct intracellular communication between tumor cells and stromas. Gap junctions and tunneling nanotube network are involved in cellular interconnections. Future investigations focused on those two modes may find a potential novel therapeutic target for treating TAE. |
Author | Mao, Xiao-Yuan Zhou, Hong-Hao Tokay, Tursonjan Jin, Wei-Lin |
AuthorAffiliation | 2 Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, P. R. China 3 Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana, Republic of Kazakhstan 4 Institute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, Key Laboratory for Thin Film and Microfabrication Technology of Ministry of Education, School of Electronic Information and Electronic Engineering, Shanghai Jiao Tong University, Shanghai, P. R. China 5 National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, P. R. China 1 Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China |
AuthorAffiliation_xml | – name: 3 Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana, Republic of Kazakhstan – name: 5 National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, P. R. China – name: 1 Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China – name: 2 Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, P. R. China – name: 4 Institute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, Key Laboratory for Thin Film and Microfabrication Technology of Ministry of Education, School of Electronic Information and Electronic Engineering, Shanghai Jiao Tong University, Shanghai, P. R. China |
Author_xml | – sequence: 1 givenname: Xiao-Yuan surname: Mao fullname: Mao, Xiao-Yuan organization: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China, Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, P. R. China – sequence: 2 givenname: Tursonjan surname: Tokay fullname: Tokay, Tursonjan organization: Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana, Republic of Kazakhstan – sequence: 3 givenname: Hong-Hao surname: Zhou fullname: Zhou, Hong-Hao organization: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China, Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, P. R. China – sequence: 4 givenname: Wei-Lin surname: Jin fullname: Jin, Wei-Lin organization: Institute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, Key Laboratory for Thin Film and Microfabrication Technology of Ministry of Education, School of Electronic Information and Electronic Engineering, Shanghai Jiao Tong University, Shanghai, P. R. China, National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, P. R. China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26967053$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1v1DAQxS1URD_vnFCOXFJsJ_66IKEKKNJKXOjZmjiTrCGxF9uh2v-etF1KQaov9sjv92Y075QchRiQkNeMXjItG_4uBhcLpBHLpTKSvyAnzLSm5kI0R0_ex-Qi5-90PaJVmptX5JhLIxUVzQnZbmIY6wRhxApCX-VtTOVQl2WOqc4lxRmqgOU2ph-5yvuAafS5eAfTtK9cDCX5bikrEA8M5Bydh4J9hTs_4S7vz8nLAaaMF4f7jNx8-vjt6rrefP385erDpnat5KVuG1Aa-ta1jFE9aEepcwphAHSSoeayb3XXiYEjSMZUp2SnuTBOcQHM0eaMvH_w3S3djL3DdTqY7C75GdLeRvD235_gt3aMv6ygSjNqVoO3B4MUfy6Yi519djhNEDAu2TLNqTCNadpV-uZpr8cmf9a7CuiDwKWYc8LhUcKovQ_R_g3R3oW4IvI_xPkCxd9tGfz0PPgbcNapcA |
CitedBy_id | crossref_primary_10_1038_onc_2017_146 crossref_primary_10_2176_jns_nmc_2023_0299 crossref_primary_10_1007_s00415_018_8857_0 crossref_primary_10_1016_j_biopha_2018_10_068 crossref_primary_10_3389_fonc_2022_989896 |
Cites_doi | 10.1016/j.clineuro.2007.05.017 10.1093/neuonc/nor205 10.1016/S0165-0173(99)00084-3 10.1111/cas.12580 10.1007/s00415-010-5637-x 10.1126/science.8134839 10.1002/glia.440150212 10.1093/neuonc/nos263 10.1212/WNL.0b013e318266fa89 10.1016/j.febslet.2009.03.065 10.4049/jimmunol.173.3.1511 10.1016/S0074-7742(06)81006-8 10.1016/j.nurt.2006.11.010 10.1016/S0301-0082(02)00013-8 10.18632/oncotarget.5253 10.1007/s11060-005-9070-4 10.18632/oncotarget.6239 10.1016/j.eplepsyres.2008.02.005 10.18632/oncotarget.5467 10.1016/j.nbd.2005.10.001 10.1111/j.1528-1167.2005.00254.x 10.1006/ebeh.2000.0071 10.1097/CCO.0b013e32833de99d 10.1177/1073858412438697 10.1038/16697 10.1002/ana.10712 10.1093/neuonc/not057 10.18632/oncotarget.5990 10.18632/oncotarget.350 10.1007/s11060-006-9162-9 10.18632/oncotarget.3904 10.1126/science.1093133 10.1016/0896-6273(91)90241-Q 10.1093/annonc/mdg371 10.1093/neuonc/nov244 10.1158/0008-5472.CAN-07-5714 10.1038/cddis.2012.177 10.18632/oncotarget.6221 10.1007/s11060-015-1975-y 10.2174/157015912800604470 10.1093/neuonc/nos152 10.1016/S0962-8924(98)01372-5 10.1158/0008-5472.CAN-13-0358 10.3988/jcn.2008.4.3.99 10.1007/s11060-010-0460-x 10.1038/nature15376 10.1007/s11060-009-9796-5 10.1016/j.cell.2011.02.013 10.3171/jns.1992.77.2.0209 10.1007/s11060-004-2338-2 10.1097/NEN.0000000000000150 10.1007/s11910-007-0053-z 10.1007/s11060-007-9430-3 10.1016/S0006-8993(01)03289-9 10.1523/JNEUROSCI.19-24-10767.1999 10.1007/s11060-009-9990-5 10.1016/j.jneumeth.2015.06.008 10.18632/oncotarget.5701 10.1093/jnci/djm187 10.1007/s12032-015-0487-0 10.1158/0008-5472.CAN-13-3629 10.1056/NEJMoa043330 10.1016/0014-4886(91)90007-Y 10.1016/0896-6273(92)90271-E 10.18632/oncotarget.6014 10.1017/S0031182005008516 10.1093/neuonc/not055 10.1016/j.eplepsyres.2005.12.002 10.1001/archneur.1995.00540310091021 10.1038/onc.2015.210 10.1023/B:NEON.0000014538.31561.bc 10.1152/jn.1999.82.4.1965 10.1002/glia.22730 10.4065/79.12.1489 10.3171/jns.1993.79.1.0062 10.1038/nature16071 10.1093/jnci/92.1.77 10.1111/j.1528-1157.1993.tb02586.x 10.1093/annonc/mdg502 10.1074/jbc.271.27.16245 10.1111/j.1528-1167.2011.03111.x 10.1007/s11912-000-0062-4 10.3171/JNS/2008/108/2/0227 10.1038/nm.2453 10.1016/j.brainresbull.2011.09.002 10.1016/j.eplepsyres.2007.04.010 10.1016/S1474-4422(07)70103-5 |
ContentType | Journal Article |
Copyright | Copyright: © 2016 Mao et al. 2016 |
Copyright_xml | – notice: Copyright: © 2016 Mao et al. 2016 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.18632/oncotarget.7962 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1949-2553 |
EndPage | 33460 |
ExternalDocumentID | PMC5078109 26967053 10_18632_oncotarget_7962 |
Genre | Journal Article Review |
GroupedDBID | --- 53G AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK FRJ GX1 HYE KQ8 M48 OK1 PGMZT RPM CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c462t-43a78ad4c41108f8c00cc7eafaec61e826d48bb5f2ea6117b76b8259c725a1c03 |
IEDL.DBID | M48 |
ISSN | 1949-2553 |
IngestDate | Thu Aug 21 18:16:55 EDT 2025 Fri Jul 11 01:40:35 EDT 2025 Thu Apr 03 06:56:57 EDT 2025 Thu Apr 24 22:53:17 EDT 2025 Tue Jul 01 01:26:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 22 |
Keywords | brain tumor short-range mode tumor microenvironment long-range mode tumor-associated epilepsy |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-43a78ad4c41108f8c00cc7eafaec61e826d48bb5f2ea6117b76b8259c725a1c03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.18632/oncotarget.7962 |
PMID | 26967053 |
PQID | 1820593934 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5078109 proquest_miscellaneous_1820593934 pubmed_primary_26967053 crossref_primary_10_18632_oncotarget_7962 crossref_citationtrail_10_18632_oncotarget_7962 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-05-31 |
PublicationDateYYYYMMDD | 2016-05-31 |
PublicationDate_xml | – month: 05 year: 2016 text: 2016-05-31 day: 31 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Oncotarget |
PublicationTitleAlternate | Oncotarget |
PublicationYear | 2016 |
Publisher | Impact Journals LLC |
Publisher_xml | – name: Impact Journals LLC |
References | Cifone (3) 2015; 6 Zhang (8) 2013; 73 Segal (1) 2000; 92 Cherubini (74) 2012; 18 Mempel (94) 2016; 18 Jandolo (37) 2008; 86 Kaila (72) 1999; 397 Nedergaard (79) 1994; 263 Hallahan (4) 2015; 6 Luddens (68) 2002; 67 Sontheimer (56) 1999; 59 Smith (78) 1992; 8 Carapella (48) 2003; 14 Villano (23) 2012; 14 Oyamada (69) 2005; 131 Zambello (54) 2015; 6 Taphoorn (88) 2016; 126 Perez Velazquez (60) 2000; 32 Sontheimer (65) 2015; 63 Zhang (91) 2012; 3 Vecht (13) 2007; 6 Cornell-Bell (82) 1995; 15 Maschio (38) 2012; 10 Godlewski (11) 2013; 15 Speckmann (30) 2006; 22 Wu (31) 1999; 82 Jiang (22) 2012; 14 Rogawski (34) 2007; 4 Li (46) 2015; 32 Scharfman (66) 2007; 7 Berger (24) 2008; 108 Nicholson (84) 2002; 929 Vecht (17) 2013; 54 Davis (93) 2004; 173 Berens (50) 2007; 99 Cheerathodi (55) 2015; 527 Naus (59) 2015; 6 Sontheimer (63) 1999; 19 Mack (2) 2015; 75 Limatola (14) 2011; 52 Vecht (87) 2013; 15 Eyupoglu (10) 2015; 106 Westbury (47) 2003; 14 Jandolo (32) 2006; 80 McCorry (43) 2010; 9 Grisold (45) 2005; 72 O'Brien (58) 2012; 79 Ludwin (7) 2005; 352 Wilkens (20) 2007; 109 Yeh (52) 2015 Sin (81) 2015; 74 Jiang (9) 2012; 14 Logsdon (49) 2008; 68 Faustmann (80) 2014; 5 Kohling (29) 2016; 260 Gerdes (92) 2009; 583 Saez (75) 1991; 6 Soffietti (25) 2012; 14 Simoes (53) 2016; 7 Delpire (71) 2000; 15 Goodenough (76) 1998; 8 Bonetti (19) 2009; 93 Karimian Jazi (89) 2015; 528 Ojemann (27) 1992; 77 Muti (33) 2011; 104 Donaldson (70) 1996; 271 Rifa (40) 2004; 66 Lah (6) 2015; 6 Zimmerman (21) 2004; 79 Gates (39) 2000; 1 Muti (41) 2010; 257 Delpire (73) 2008; 79 Abou-Khalil (16) 1995; 52 Pearl (36) 2006; 78 Kurland (15) 1993; 34 Paul (83) 1991; 111 Pumain (61) 2006; 69 Li (5) 2016; 7 Kwon (42) 2008; 4 Szente (85) 2005; 46 Gerdes (90) 2004; 303 Sontheimer (64) 2015; 7 Weinberg (51) 2011; 144 Soffietti (18) 2010; 22 Sontheimer (57) 2011; 17 Van Meir (12) 2000; 2 Amanzadeh (86) 2007; 75 Ojemann (26) 1993; 79 Hutchinson (62) 2010; 97 Heimans (44) 2003; 54 Sontheimer (28) 2011; 2 Wilcox (35) 2007; 81 Cao (67) 2011; 86 Naus (77) 2015 |
References_xml | – volume: 109 start-page: 634 year: 2007 ident: 20 article-title: Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2007.05.017 – volume: 14 start-page: 230 year: 2012 ident: 22 article-title: Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study publication-title: Neuro Oncol doi: 10.1093/neuonc/nor205 – volume: 32 start-page: 235 year: 2000 ident: 60 article-title: The role of gap junctions in seizures publication-title: Brain Res Brain Res Rev doi: 10.1016/S0165-0173(99)00084-3 – volume: 54 start-page: 12 issue: Suppl 9 year: 2013 ident: 17 article-title: Seizure characteristics and prognostic factors of gliomas publication-title: Epilepsia – volume: 106 start-page: 160 year: 2015 ident: 10 article-title: Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment publication-title: Cancer Sci doi: 10.1111/cas.12580 – volume: 257 start-page: 1939 year: 2010 ident: 41 article-title: Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy publication-title: J Neurol doi: 10.1007/s00415-010-5637-x – volume: 263 start-page: 1768 year: 1994 ident: 79 article-title: Direct signaling from astrocytes to neurons in cultures of mammalian brain cells publication-title: Science doi: 10.1126/science.8134839 – volume: 15 start-page: 195 year: 1995 ident: 82 article-title: Human epileptic astrocytes exhibit increased gap junction coupling publication-title: Glia doi: 10.1002/glia.440150212 – volume: 9 start-page: 138 year: 2010 ident: 43 article-title: Behavioral and cognitive effects of anti-epileptic drugs publication-title: Discov Med – volume: 14 start-page: 1432 year: 2012 ident: 9 article-title: Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group publication-title: Neuro Oncol doi: 10.1093/neuonc/nos263 – volume: 5 start-page: 186 year: 2014 ident: 80 article-title: Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro publication-title: Front Physiol – volume: 79 start-page: 883 year: 2012 ident: 58 article-title: Glutamate is associated with a higher risk of seizures in patients with gliomas publication-title: Neurology doi: 10.1212/WNL.0b013e318266fa89 – volume: 583 start-page: 1481 year: 2009 ident: 92 article-title: Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells publication-title: FEBS Lett doi: 10.1016/j.febslet.2009.03.065 – volume: 173 start-page: 1511 year: 2004 ident: 93 article-title: Cutting edge: Membrane nanotubes connect immune cells publication-title: J Immunol doi: 10.4049/jimmunol.173.3.1511 – volume: 81 start-page: 85 year: 2007 ident: 35 article-title: Mechanisms of action of antiepileptic drugs publication-title: Int Rev Neurobiol doi: 10.1016/S0074-7742(06)81006-8 – volume: 4 start-page: 18 year: 2007 ident: 34 article-title: Molecular targets for antiepileptic drug development publication-title: Neurotherapeutics doi: 10.1016/j.nurt.2006.11.010 – volume: 67 start-page: 113 year: 2002 ident: 68 article-title: Drug interactions at GABA(A) receptors publication-title: Prog Neurobiol doi: 10.1016/S0301-0082(02)00013-8 – volume: 6 start-page: 35004 year: 2015 ident: 4 article-title: Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells publication-title: Oncotarget doi: 10.18632/oncotarget.5253 – volume: 78 start-page: 99 year: 2006 ident: 36 article-title: Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients publication-title: J Neurooncol doi: 10.1007/s11060-005-9070-4 – volume: 6 start-page: 42130 year: 2015 ident: 54 article-title: Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival publication-title: Oncotarget doi: 10.18632/oncotarget.6239 – volume: 79 start-page: 201 year: 2008 ident: 73 article-title: NKCC1 and KCC2 prevent hyperexcitability in the mouse hippocampus publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2008.02.005 – year: 2015 ident: 52 article-title: Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERbeta/CCL2/CCR2 EMT/MMP9 signals publication-title: Oncotarget doi: 10.18632/oncotarget.5467 – volume: 22 start-page: 64 year: 2006 ident: 30 article-title: Epileptiform activity preferentially arises outside tumor invasion zone in glioma xenotransplants publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2005.10.001 – volume: 46 start-page: 1581 year: 2005 ident: 85 article-title: Quinine, a blocker of neuronal cx36 channels, suppresses seizure activity in rat neocortex in vivo publication-title: Epilepsia doi: 10.1111/j.1528-1167.2005.00254.x – volume: 7 start-page: 289ra286 year: 2015 ident: 64 article-title: SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma publication-title: Sci Transl Med – volume: 59 start-page: 4383 year: 1999 ident: 56 article-title: Glioma cells release excitotoxic concentrations of glutamate publication-title: Cancer Res – volume: 1 start-page: 153 year: 2000 ident: 39 article-title: Side effect profiles and behavioral consequences of antiepileptic medications publication-title: Epilepsy Behav doi: 10.1006/ebeh.2000.0071 – volume: 22 start-page: 611 year: 2010 ident: 18 article-title: Epilepsy and brain tumors publication-title: Curr Opin Oncol doi: 10.1097/CCO.0b013e32833de99d – volume: 18 start-page: 467 year: 2012 ident: 74 article-title: The GABA excitatory/inhibitory shift in brain maturation and neurological disorders publication-title: Neuroscientist doi: 10.1177/1073858412438697 – volume: 397 start-page: 251 year: 1999 ident: 72 article-title: The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation publication-title: Nature doi: 10.1038/16697 – volume: 54 start-page: 514 year: 2003 ident: 44 article-title: Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life publication-title: Ann Neurol doi: 10.1002/ana.10712 – volume: 15 start-page: 961 year: 2013 ident: 87 article-title: Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme publication-title: Neuro Oncol doi: 10.1093/neuonc/not057 – volume: 6 start-page: 42091 year: 2015 ident: 3 article-title: Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model publication-title: Oncotarget doi: 10.18632/oncotarget.5990 – volume: 2 start-page: 823 year: 2011 ident: 28 article-title: Glutamate and tumor-associated epilepsy publication-title: Oncotarget doi: 10.18632/oncotarget.350 – volume: 80 start-page: 97 year: 2006 ident: 32 article-title: Levetiracetam therapy in patients with brain tumour and epilepsy publication-title: J Neurooncol doi: 10.1007/s11060-006-9162-9 – volume: 6 start-page: 15566 year: 2015 ident: 59 article-title: Gap junctions modulate glioma invasion by direct transfer of microRNA publication-title: Oncotarget doi: 10.18632/oncotarget.3904 – volume: 303 start-page: 1007 year: 2004 ident: 90 article-title: Nanotubular highways for intercellular organelle transport publication-title: Science doi: 10.1126/science.1093133 – volume: 6 start-page: 305 year: 1991 ident: 75 article-title: Gap junctions: new tools, new answers, new questions publication-title: Neuron doi: 10.1016/0896-6273(91)90241-Q – volume: 14 start-page: 1715 year: 2003 ident: 47 article-title: Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas publication-title: Ann Oncol doi: 10.1093/annonc/mdg371 – volume: 18 start-page: 58 year: 2016 ident: 94 article-title: Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain publication-title: Neuro Oncol doi: 10.1093/neuonc/nov244 – volume: 68 start-page: 918 year: 2008 ident: 49 article-title: Cancer-associated stromal fibroblasts promote pancreatic tumor progression publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-5714 – volume: 3 start-page: e438 year: 2012 ident: 91 article-title: Tunneling-nanotube direction determination in neurons and astrocytes publication-title: Cell Death Dis doi: 10.1038/cddis.2012.177 – volume: 7 start-page: 2354 year: 2016 ident: 5 article-title: Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma publication-title: Oncotarget doi: 10.18632/oncotarget.6221 – volume: 126 start-page: 347 year: 2016 ident: 88 article-title: Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide publication-title: J Neurooncol doi: 10.1007/s11060-015-1975-y – volume: 10 start-page: 124 year: 2012 ident: 38 article-title: Brain tumor-related epilepsy publication-title: Curr Neuropharmacol doi: 10.2174/157015912800604470 – volume: 14 start-page: 1171 year: 2012 ident: 23 article-title: Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data publication-title: Neuro Oncol doi: 10.1093/neuonc/nos152 – volume: 8 start-page: 477 year: 1998 ident: 76 article-title: Diverse functions of vertebrate gap junctions publication-title: Trends Cell Biol doi: 10.1016/S0962-8924(98)01372-5 – volume: 73 start-page: 6046 year: 2013 ident: 8 article-title: MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-0358 – volume: 4 start-page: 99 year: 2008 ident: 42 article-title: Cognitive effects of antiepileptic drugs publication-title: J Clin Neurol doi: 10.3988/jcn.2008.4.3.99 – volume: 104 start-page: 205 year: 2011 ident: 33 article-title: Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life publication-title: J Neurooncol doi: 10.1007/s11060-010-0460-x – volume: 527 start-page: 100 year: 2015 ident: 55 article-title: Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth publication-title: Nature doi: 10.1038/nature15376 – volume: 93 start-page: 395 year: 2009 ident: 19 article-title: Epilepsy in cerebral glioma: timing of appearance and histological correlations publication-title: J Neurooncol doi: 10.1007/s11060-009-9796-5 – volume: 144 start-page: 646 year: 2011 ident: 51 article-title: Hallmarks of cancer: the next generation publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 14 start-page: iv55 issue: Suppl 4 year: 2012 ident: 25 article-title: Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments publication-title: Neuro Oncol – volume: 77 start-page: 209 year: 1992 ident: 27 article-title: Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas publication-title: J Neurosurg doi: 10.3171/jns.1992.77.2.0209 – volume: 72 start-page: 255 year: 2005 ident: 45 article-title: P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy publication-title: J Neurooncol doi: 10.1007/s11060-004-2338-2 – volume: 74 start-page: 64 year: 2015 ident: 81 article-title: Podoplanin: a marker for reactive gliosis in gliomas and brain injury publication-title: J Neuropathol Exp Neurol doi: 10.1097/NEN.0000000000000150 – volume: 7 start-page: 348 year: 2007 ident: 66 article-title: The neurobiology of epilepsy publication-title: Curr Neurol Neurosci Rep doi: 10.1007/s11910-007-0053-z – volume: 86 start-page: 61 year: 2008 ident: 37 article-title: Outcome and tolerability of topiramate in brain tumor associated epilepsy publication-title: J Neurooncol doi: 10.1007/s11060-007-9430-3 – volume: 929 start-page: 105 year: 2002 ident: 84 article-title: Upregulation in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy publication-title: Brain Res doi: 10.1016/S0006-8993(01)03289-9 – volume: 19 start-page: 10767 year: 1999 ident: 63 article-title: Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange publication-title: J Neurosci doi: 10.1523/JNEUROSCI.19-24-10767.1999 – volume: 97 start-page: 11 year: 2010 ident: 62 article-title: In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines publication-title: J Neurooncol doi: 10.1007/s11060-009-9990-5 – volume: 260 start-page: 109 year: 2016 ident: 29 article-title: Animal models of tumour-associated epilepsy publication-title: J Neurosci Methods doi: 10.1016/j.jneumeth.2015.06.008 – volume: 6 start-page: 40998 year: 2015 ident: 6 article-title: Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance publication-title: Oncotarget doi: 10.18632/oncotarget.5701 – volume: 99 start-page: 1583 year: 2007 ident: 50 article-title: Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djm187 – volume: 32 start-page: 43 year: 2015 ident: 46 article-title: Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes publication-title: Med Oncol doi: 10.1007/s12032-015-0487-0 – volume: 75 start-page: 134 year: 2015 ident: 2 article-title: Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-3629 – volume: 352 start-page: 987 year: 2005 ident: 7 article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma publication-title: N Engl J Med doi: 10.1056/NEJMoa043330 – volume: 111 start-page: 198 year: 1991 ident: 83 article-title: Gap junction gene expression in human seizure disorder publication-title: Exp Neurol doi: 10.1016/0014-4886(91)90007-Y – volume: 8 start-page: 429 year: 1992 ident: 78 article-title: Neuronal activity triggers calcium waves in hippocampal astrocyte networks publication-title: Neuron doi: 10.1016/0896-6273(92)90271-E – volume: 7 start-page: 1262 year: 2016 ident: 53 article-title: Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity publication-title: Oncotarget doi: 10.18632/oncotarget.6014 – volume: 131 start-page: 775 year: 2005 ident: 69 article-title: Molecular characterization of a putative protein disulfide isomerase from Babesia caballi publication-title: Parasitology doi: 10.1017/S0031182005008516 – volume: 15 start-page: 1212 year: 2013 ident: 11 article-title: MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells publication-title: Neuro Oncol doi: 10.1093/neuonc/not055 – volume: 69 start-page: 15 year: 2006 ident: 61 article-title: Effects in vitro and in vivo of a gap junction blocker on epileptiform activities in a genetic model of absence epilepsy publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2005.12.002 – volume: 52 start-page: 717 year: 1995 ident: 16 article-title: The course of seizure disorders in patients with malignant gliomas publication-title: Arch Neurol doi: 10.1001/archneur.1995.00540310091021 – year: 2015 ident: 77 article-title: Astrocytes promote glioma invasion via the gap junction protein connexin43 publication-title: Oncogene doi: 10.1038/onc.2015.210 – volume: 66 start-page: 345 year: 2004 ident: 40 article-title: Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider publication-title: J Neurooncol doi: 10.1023/B:NEON.0000014538.31561.bc – volume: 82 start-page: 1965 year: 1999 ident: 31 article-title: Epileptiform activity can be initiated in various neocortical layers: an optical imaging study publication-title: J Neurophysiol doi: 10.1152/jn.1999.82.4.1965 – volume: 63 start-page: 23 year: 2015 ident: 65 article-title: GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy publication-title: Glia doi: 10.1002/glia.22730 – volume: 79 start-page: 1489 year: 2004 ident: 21 article-title: Seizure prophylaxis in patients with brain tumors: a meta-analysis publication-title: Mayo Clin Proc doi: 10.4065/79.12.1489 – volume: 79 start-page: 62 year: 1993 ident: 26 article-title: Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection publication-title: J Neurosurg doi: 10.3171/jns.1993.79.1.0062 – volume: 528 start-page: 93 year: 2015 ident: 89 article-title: Brain tumour cells interconnect to a functional and resistant network publication-title: Nature doi: 10.1038/nature16071 – volume: 92 start-page: 77 year: 2000 ident: 1 article-title: Re: Brain and other central nervous system cancers: recent trends in incidence and mortality publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.1.77 – volume: 34 start-page: 453 year: 1993 ident: 15 article-title: Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984 publication-title: Epilepsia doi: 10.1111/j.1528-1157.1993.tb02586.x – volume: 14 start-page: 1722 year: 2003 ident: 48 article-title: Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response publication-title: Ann Oncol doi: 10.1093/annonc/mdg502 – volume: 271 start-page: 16245 year: 1996 ident: 70 article-title: Molecular characterization of a putative K-Cl cotransporter in rat brain. A neuronal-specific isoform publication-title: J Biol Chem doi: 10.1074/jbc.271.27.16245 – volume: 52 start-page: 1635 year: 2011 ident: 14 article-title: Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex publication-title: Epilepsia doi: 10.1111/j.1528-1167.2011.03111.x – volume: 2 start-page: 425 year: 2000 ident: 12 article-title: Application of advances in molecular biology to the treatment of brain tumors publication-title: Curr Oncol Rep doi: 10.1007/s11912-000-0062-4 – volume: 15 start-page: 309 year: 2000 ident: 71 article-title: Cation-Chloride Cotransporters in Neuronal Communication publication-title: News Physiol Sci – volume: 108 start-page: 227 year: 2008 ident: 24 article-title: Seizure characteristics and control following resection in 332 patients with low-grade gliomas publication-title: J Neurosurg doi: 10.3171/JNS/2008/108/2/0227 – volume: 17 start-page: 1269 year: 2011 ident: 57 article-title: Glutamate release by primary brain tumors induces epileptic activity publication-title: Nat Med doi: 10.1038/nm.2453 – volume: 86 start-page: 373 year: 2011 ident: 67 article-title: Altered expression of GABAA receptors (alpha4, gamma2 subunit), potassium chloride cotransporter 2 and astrogliosis in tremor rat hippocampus publication-title: Brain Res Bull doi: 10.1016/j.brainresbull.2011.09.002 – volume: 75 start-page: 97 year: 2007 ident: 86 article-title: Intra-amygdala all-trans retinoic acid inhibits amygdala-kindled seizures in rats publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2007.04.010 – volume: 6 start-page: 421 year: 2007 ident: 13 article-title: Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management publication-title: Lancet Neurol doi: 10.1016/S1474-4422(07)70103-5 |
SSID | ssj0000547829 |
Score | 2.1351798 |
SecondaryResourceType | review_article |
Snippet | Epileptic seizures are frequently caused by brain tumors. Traditional anti-epileptic treatments do not acquire satisfactory responses. Preoperative and... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 33451 |
SubjectTerms | Animals Anticonvulsants - therapeutic use Brain - drug effects Brain - metabolism Brain - pathology Brain - physiopathology Brain Neoplasms - metabolism Brain Neoplasms - pathology Brain Neoplasms - physiopathology Brain Waves - drug effects Epilepsy - drug therapy Epilepsy - metabolism Epilepsy - pathology Epilepsy - physiopathology GABAergic Neurons - metabolism GABAergic Neurons - pathology Gap Junctions - drug effects Gap Junctions - metabolism Gap Junctions - pathology Humans Interneurons - metabolism Interneurons - pathology Paracrine Communication - drug effects Review Signal Transduction - drug effects Stromal Cells - drug effects Stromal Cells - metabolism Stromal Cells - pathology |
Title | Long-range and short-range tumor-stroma networks synergistically contribute to tumor-associated epilepsy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26967053 https://www.proquest.com/docview/1820593934 https://pubmed.ncbi.nlm.nih.gov/PMC5078109 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8QwEA4-Ll5E8bU-lgpePET7SJPmICLiA3E9ubC3kqSpK9R2bbvg_nszbXbXVRGPpUlKZzIvZuYbhE4SXzMNHT0BSzkmSnlYyERjKWQkFCdh0oxO6D3R-z55GISDeXu0JWD1a2gH86T6ZXb28T65NAJ_AQIf0cA_LwDHoCmcPmMcFPKqsUsMxLRnnf0W6ZsYc8ibNDPh2PjSgc1b_nbIop364Xx-r6H8YpRuN9C69Sadq5b9m2hJ51to-FjkL7iErgFH5IlTDc3f2ed6_FaUuKrL4k04eVsCXjnVBDoAG8hmkWUTp6lfh0FYZkNh9wjLR504emRUyaiabKP-7c3z9T22AxWwItSvMQkEi0RCFIHi_zRSrqsU0yIVWlFPm0gjIZGUYeprQT2PSUaliSC5Yn4oPOUGO2glL3K9hxwepUaNhjTiKiKJJiL1zDEB19QEUGkoO-h8Sr5YWbRxGHqRxRB1AMHjOcFjIHgHnc52jFqkjT_WHk85EhtxgByHyHUxrmLAow95wAPSQbsth2an-ZRTZpROB7EF3s0WANT24pv8ddhAboeAieTy_X989wCtGaeKthUGh2ilLsf6yDguteyi5buB121u5Sd35vZf |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-range+and+short-range+tumor-stroma+networks+synergistically+contribute+to+tumor-associated+epilepsy&rft.jtitle=Oncotarget&rft.au=Mao%2C+Xiao-Yuan&rft.au=Tokay%2C+Tursonjan&rft.au=Zhou%2C+Hong-Hao&rft.au=Jin%2C+Wei-Lin&rft.date=2016-05-31&rft.issn=1949-2553&rft.eissn=1949-2553&rft.volume=7&rft.issue=22&rft.spage=33451&rft_id=info:doi/10.18632%2Foncotarget.7962&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-2553&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-2553&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-2553&client=summon |